FPR1 mediates the tumorigenicity of human cervical cancer cells

References

• IslamiFTorreLADropeJMWardEMJemalAGlobal cancer in women: cancer control prioritiesCancer Epidemiol Biomarkers Prev201726445847028183824
   PubMed Web of Science ®Google Scholar
• TorreLABrayFSiegelRLFerlayJLortet-TieulentJJemalAGlobal cancer statistics, 2012CA Cancer J Clin20156528710825651787
   PubMed Web of Science ®Google Scholar
• SalicrúSRde La TorreJFGil-MorenoAThe surgical management of early-stage cervical cancerCurr Opin Obstet Gynecol201325431231923787798
   PubMed Web of Science ®Google Scholar
• MarshallCRajdevMASomarouthuBRamaiyaNHAlessandrinoFOverview of systemic treatment in recurrent and advanced cervical cancer: a primer for radiologistsAbdom Radiol2018
   Web of Science ®Google Scholar
• LiuMChenKYoshimuraTFormylpeptide receptors mediate rapid neutrophil mobilization to accelerate wound healingPLoS One201496e9061324603667
   PubMed Web of Science ®Google Scholar
• VacchelliEMaYBaraccoEEChemotherapy-induced antitumor immunity requires formyl peptide receptor 1Science2015350626397297826516201
   PubMed Web of Science ®Google Scholar
• BelvedereRBizzarroVPopoloARole of intracellular and extracellular annexin A1 in migration and invasion of human pancreatic carcinoma cellsBMC Cancer20141496125510623
   PubMed Web of Science ®Google Scholar
• BoerJCvan MarionDMJosephJVMicroenvironment involved in FPR1 expression by human glioblastomasJ Neurooncol20151231536325894595
   PubMed Web of Science ®Google Scholar
• LeYYeRDGongWLiJIribarrenPWangJMIdentification of functional domains in the formyl peptide receptor-like 1 for agonist-induced cell chemotaxisFebs J2005272376977815670157
   PubMed Web of Science ®Google Scholar
• HuangSChenLYZurawBLYeRDPanZKChemoattractant-stimulated NF-kappaB activation is dependent on the low molecular weight GTPase RhoAJ Biol Chem200127644409774098111533055
   PubMed Web of Science ®Google Scholar
• JoEJLeeHYKimJIActivation of formyl peptide receptor-like 1 by WKYMVm induces serine phosphorylation of STAT3, which inhibits its tyrosine phosphorylation and nuclear translocation induced by hydrogen peroxideLife Sci200475182217223215325847
   PubMed Web of Science ®Google Scholar
• LiuFCYuHPSyuYTHonokiol suppresses formyl peptide-induced human neutrophil activation by blocking formyl peptide receptor 1Sci Rep201771671828751674
   PubMedGoogle Scholar
• ShiYLaiXYeLActivated niacin receptor HCA2 inhibits chemoattractant-mediated macrophage migration via Gβγ/PKC/ERK1/2 pathway and heterologous receptor desensitizationSci Rep201774227928186140
   PubMed Web of Science ®Google Scholar
• WangXQinWSongMZhangYSunBExogenous carbon monoxide inhibits neutrophil infiltration in LPS-induced sepsis by interfering with FPR1 via p38 MAPK but not GRK2Oncotarget2016723342503426527144520
   PubMedGoogle Scholar
• SinghRMishraMKAggarwalHInflammation, immunity, and cancerMediators Inflamm20172017602730529234189
   PubMed Web of Science ®Google Scholar
• WuYDongYDuanSZhuDDengLMetabolic syndrome, inflammation, and cancerMediators Inflamm201720178259356229302133
   PubMed Web of Science ®Google Scholar
• KinoshitaTItoHMikiCSerum interleukin-6 level reflects the tumor proliferative activity in patients with colorectal carcinomaCancer199985122526253110375098
   PubMed Web of Science ®Google Scholar
• LimaSFTavaresMMMacedoJLInfluence of IL-6, IL-8, and TGF-β1 gene polymorphisms on the risk of human papillomavirus-infection in women from Pernambuco, BrazilMem Inst Oswaldo Cruz20161111166366927783717
   PubMed Web of Science ®Google Scholar
• WeiLHKuoMLChenCAInterleukin-6 in cervical cancer: the relationship with vascular endothelial growth factorGynecol Oncol2001821495611426961
   PubMed Web of Science ®Google Scholar
• JiaLLiFShaoMIL-8 is upregulated in cervical cancer tissues and is associated with the proliferation and migration of HeLa cervical cancer cellsOncol Lett20181511350135629399185
   PubMed Web of Science ®Google Scholar
• TartourEGeyASastre-GarauXAnalysis of interleukin 6 gene expression in cervical neoplasia using a quantitative polymerase chain reaction assay: evidence for enhanced interleukin 6 gene expression in invasive carcinomaCancer Res19945423624362487954473
   PubMed Web of Science ®Google Scholar
• AnglesioMSGeorgeJKulbeHIL6-STAT3-HIF signaling and therapeutic response to the angiogenesis inhibitor sunitinib in ovarian clear cell cancerClin Cancer Res2011172538254821343371
   PubMed Web of Science ®Google Scholar
• RadziejewskaIBorzym-KluczykMLeszczyńskaKWosekJBielawskaALotus tetragonolobus and Maackia amurensis lectins influence phospho-IκBα, IL-8, Lewis b and H type 1 glycoforms levels in H. pylori infected CRL-1739 gastric cancer cellsAdv Med Sci201863120521129197783
   PubMed Web of Science ®Google Scholar
• ZouMZhangXXuCIL6-induced metastasis modulators p-STAT3, MMP-2 and MMP-9 are targets of 3,3’-diindolylmethane in ovarian cancer cellsCell Oncol20163914757
   Web of Science ®Google Scholar
• ChengTYWuMSLinJTFormyl Peptide receptor 1 expression is associated with tumor progression and survival in gastric cancerAnticancer Res20143452223222924778024
   PubMed Web of Science ®Google Scholar
• LammersKMChieppaMLiuLGliadin induces neutrophil migration via engagement of the formyl peptide receptor, FPR1PLoS One2015109e013833826378785
   PubMed Web of Science ®Google Scholar
• FarooqSMStadnykAWNeutrophil infiltration of the colon is independent of the FPR1 yet FPR1 deficient mice show differential susceptibilities to acute versus chronic induced colitisDig Dis Sci20125771802181222383080
   PubMed Web of Science ®Google Scholar
• MorrisSVachaniAPassHIWhole blood FPR1 mRNA expression predicts both non-small cell and small cell lung cancerInt J Cancer2018142112355236229313979
   PubMed Web of Science ®Google Scholar
• VecchiLAlves Pereira ZóiaMGoss SantosTInhibition of the AnxA1/FPR1 autocrine axis reduces MDA-MB-231 breast cancer cell growth and aggressiveness in vitro and in vivoBiochim Biophys Acta Mol Cell Res2018186591368138229932988
   PubMed Web of Science ®Google Scholar
• ZhangLWangHYangTFormylpeptide receptor 1 mediates the tumorigenicity of human hepatocellular carcinoma cellsOncoimmunology201652e107805527057451
   PubMed Web of Science ®Google Scholar
• PreveteNLiottiFViscianoCMaroneGMelilloRMde PaulisAThe formyl peptide receptor 1 exerts a tumor suppressor function in human gastric cancer by inhibiting angiogenesisOncogene201534293826383825263443
   PubMed Web of Science ®Google Scholar
• ZhangXWangTYuanZCMitochondrial peptides cause proinflammatory responses in the alveolar epithelium via FPR-1 MAPKs, and AKT: a potential mechanism involved in acute lung injuryAm J Physiol Lung Cell Mol Physiol2018
   Web of Science ®Google Scholar
• AhmadNAmmarAStorrSJIL-6 and IL-10 are associated with good prognosis in early stage invasive breast cancer patientsCancer Immunol Immunother201867453754929256156
   PubMed Web of Science ®Google Scholar
• DingSTangZJiangYIL-8 is involved in estrogen-related receptor α-regulated proliferation and migration of colorectal cancer cellsDig Dis Sci201762123438344628993941
   PubMed Web of Science ®Google Scholar
• FuQLiuPSunXRibonucleic acid interference knockdown of IL-6 enhances the efficacy of cisplatin in laryngeal cancer stem cells by down-regulating the IL-6/STAT3/HIF1 pathwayCancer Cell Int2017177928878571
   PubMed Web of Science ®Google Scholar
• KimWPyoJNohBJJeongJWLeeJKimJECCAR2 negatively regulates IL-8 production in cervical cancer cellsOncotarget2018911143115529416683
   PubMedGoogle Scholar
• SanguineteMMMOliveiraPHMartins-FilhoASerum IL-6 and IL-8 correlate with prognostic factors in ovarian cancerImmunol Invest201746767768828872976
   PubMed Web of Science ®Google Scholar
• ChevrelGGarneroPMiossecPAddition of interleukin 1 (IL1) and IL17 soluble receptors to a tumour necrosis factor alpha soluble receptor more effectively reduces the production of IL6 and macrophage inhibitory protein-3alpha and increases that of collagen in an in vitro model of rheumatoid synoviocyte activationAnn Rheum Dis200261873073312117682
   PubMed Web of Science ®Google Scholar
• GrünwaldBVandoorenJGergMSystemic ablation of MMP-9 triggers invasive growth and metastasis of pancreatic cancer via deregulation of IL6 expression in the bone marrowMol Cancer Res201614111147115827489361
   PubMed Web of Science ®Google Scholar